Contrasting serum biomarker profiles in two Colombian populations with different risks for progression of premalignant gastric lesions during chronic Helicobacter pylori infection
•Coastal Colombians have lower Helicobacter pylori-associated gastric cancer compared to the Andes despite comparable infection and gastritis.•Lesion progression was associated with significant odds ratios for serum IL-5, trefoil factor 3 (TFF3), and low pepsinogen I/II ratio.•Low risk patients had...
Gespeichert in:
Veröffentlicht in: | Cancer epidemiology 2020-08, Vol.67, p.101726-101726, Article 101726 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 101726 |
---|---|
container_issue | |
container_start_page | 101726 |
container_title | Cancer epidemiology |
container_volume | 67 |
creator | Whary, Mark T. Avenia, Jose M. Restrepo Bravo, Luis E. Lofgren, Jennifer L. Lertpiriyapong, Kvin Mera-Giler, Robertino Piazuelo, M. Blanca Correa, Pelayo Peek, Richard M. Wilson, Keith T. Fox, James G. |
description | •Coastal Colombians have lower Helicobacter pylori-associated gastric cancer compared to the Andes despite comparable infection and gastritis.•Lesion progression was associated with significant odds ratios for serum IL-5, trefoil factor 3 (TFF3), and low pepsinogen I/II ratio.•Low risk patients had elevated serum inflammatory biomarkers that reflect higher exposure to infectious diseases beyond H. pylori.•Data suggest IL-5, TFF3 and pepsinogen I/II ratios should be evaluated in combination to predict aggressive gastric histology.
Colombians in coastal Tumaco have a lower incidence of Helicobacter pylori-associated gastric cancer compared to individuals from Tuquerres in the high Andes. This is despite nearly universal prevalence of H. pylori infection and chronic gastritis.
H. pylori infection was confirmed by Steiner stain and serology using African and European-origin strains. Gastric histology and serum inflammatory biomarkers in dyspeptic Tumaco or Tuquerres patients were evaluated to predict progression of gastric lesions.
H. pylori infection was nearly universal by Steiner stain and serology. IgG response to European-origin H. pylori strains were greater than African-origin. High gastric cancer-risk Tuquerres patients, compared to low-risk Tumaco, had significant odds ratios for lesion progression associated with serum IL-5, trefoil factor 3 (TFF3), and low pepsinogen I/II ratio. Sensitivity and specificity for these parameters was 63.8% and 67.9%, respectively, with correctly classifying patients at 66.7%. Most odds ratios for 26 other biomarkers were significant for the town of residency, indicating an environmental impact on Tumaco patients associated with decreased lesion progression.
An IL-5 association with progression of gastric lesions is novel and could be evaluated in addition to TFF3 and pepsinogen I/II ratio as a non-invasive prognostic screen. Results suggest Tumaco patients were exposed to infectious diseases beyond H. pylori such as the documented high incidence of helminthiasis and toxoplasmosis.
Results support a prior recommendation to evaluate TFF3 and pepsinogen I/II together to predict aggressive gastric histology. Our data indicate IL-5 should be further evaluated as prognostic parameter. |
doi_str_mv | 10.1016/j.canep.2020.101726 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7755565</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1877782120300606</els_id><sourcerecordid>2425586865</sourcerecordid><originalsourceid>FETCH-LOGICAL-c487t-60c29872f99c7970de4c8819b9b2f0eb6d43057cfd543980d99a6249f023f13b3</originalsourceid><addsrcrecordid>eNp9Uk1v1DAUjBCIlsIvQEKWuHDZxXE-HB9AqlZAkSpxAYmb5TjP2bd17GAnrfq7-IM42bICDpxsP8-bNx5Plr3M6Tanef32sNXKwbhllK0VzupH2XnecL7hTfH98WnP8rPsWYwHSus6z6un2VnBypKzkp1nP3feTUHFCV1PIoR5IC36QYUbCGQM3qCFSNCR6c6Tnbd-aFE5MvpxtmpC7yK5w2lPOjQGAriJBIw3kRi_tvcBYkwo4k06wqAs9k4lVJ9GBtQksa8k3RwWBXofvEvlK7Cofav0tMi4tz5gEmFALyOfZ0-MshFePKwX2bePH77urjbXXz593l1eb3TZ8GlTU81Ew5kRQnPBaQelbppctKJlhkJbd2VBK65NV5WFaGgnhKpZKQxlhcmLtrjI3h95x7kdoNOwOGXlGDD5cy-9Qvn3jcO97P2t5LyqqrpKBG8eCIL_MUOc5IBRg7Xp3_wcJStpXXFGqUjQ1_9AD34OLj0voVhVNXWzEhZHlA4-xgDmJCancgmFPMg1FHIJhTyGInW9-vMdp57fKUiAd0cAJDdvEYKMGsFp6DAky2Xn8b8DfgFt5c9s</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2425586865</pqid></control><display><type>article</type><title>Contrasting serum biomarker profiles in two Colombian populations with different risks for progression of premalignant gastric lesions during chronic Helicobacter pylori infection</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Whary, Mark T. ; Avenia, Jose M. Restrepo ; Bravo, Luis E. ; Lofgren, Jennifer L. ; Lertpiriyapong, Kvin ; Mera-Giler, Robertino ; Piazuelo, M. Blanca ; Correa, Pelayo ; Peek, Richard M. ; Wilson, Keith T. ; Fox, James G.</creator><creatorcontrib>Whary, Mark T. ; Avenia, Jose M. Restrepo ; Bravo, Luis E. ; Lofgren, Jennifer L. ; Lertpiriyapong, Kvin ; Mera-Giler, Robertino ; Piazuelo, M. Blanca ; Correa, Pelayo ; Peek, Richard M. ; Wilson, Keith T. ; Fox, James G.</creatorcontrib><description>•Coastal Colombians have lower Helicobacter pylori-associated gastric cancer compared to the Andes despite comparable infection and gastritis.•Lesion progression was associated with significant odds ratios for serum IL-5, trefoil factor 3 (TFF3), and low pepsinogen I/II ratio.•Low risk patients had elevated serum inflammatory biomarkers that reflect higher exposure to infectious diseases beyond H. pylori.•Data suggest IL-5, TFF3 and pepsinogen I/II ratios should be evaluated in combination to predict aggressive gastric histology.
Colombians in coastal Tumaco have a lower incidence of Helicobacter pylori-associated gastric cancer compared to individuals from Tuquerres in the high Andes. This is despite nearly universal prevalence of H. pylori infection and chronic gastritis.
H. pylori infection was confirmed by Steiner stain and serology using African and European-origin strains. Gastric histology and serum inflammatory biomarkers in dyspeptic Tumaco or Tuquerres patients were evaluated to predict progression of gastric lesions.
H. pylori infection was nearly universal by Steiner stain and serology. IgG response to European-origin H. pylori strains were greater than African-origin. High gastric cancer-risk Tuquerres patients, compared to low-risk Tumaco, had significant odds ratios for lesion progression associated with serum IL-5, trefoil factor 3 (TFF3), and low pepsinogen I/II ratio. Sensitivity and specificity for these parameters was 63.8% and 67.9%, respectively, with correctly classifying patients at 66.7%. Most odds ratios for 26 other biomarkers were significant for the town of residency, indicating an environmental impact on Tumaco patients associated with decreased lesion progression.
An IL-5 association with progression of gastric lesions is novel and could be evaluated in addition to TFF3 and pepsinogen I/II ratio as a non-invasive prognostic screen. Results suggest Tumaco patients were exposed to infectious diseases beyond H. pylori such as the documented high incidence of helminthiasis and toxoplasmosis.
Results support a prior recommendation to evaluate TFF3 and pepsinogen I/II together to predict aggressive gastric histology. Our data indicate IL-5 should be further evaluated as prognostic parameter.</description><identifier>ISSN: 1877-7821</identifier><identifier>EISSN: 1877-783X</identifier><identifier>DOI: 10.1016/j.canep.2020.101726</identifier><identifier>PMID: 32447242</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Adult ; Biomarkers ; Biomarkers - blood ; Biopsy ; Cancer ; Case-Control Studies ; Chemokines ; Chronic infection ; Colombia ; Colombia - epidemiology ; Cytokines ; Environmental impact ; Epidemiology ; Evaluation ; Female ; Gastric cancer ; Gastritis ; Health risks ; Helicobacter Infections - complications ; Helicobacter Infections - virology ; Helicobacter pylori ; Helicobacter pylori - isolation & purification ; Helminthiasis ; Histology ; Histopathology ; Humans ; Immunoglobulin G ; Incidence ; Infections ; Infectious diseases ; Inflammation ; Interleukin 5 ; Interleukin-5 - blood ; Lesions ; Male ; Middle Aged ; Parameter sensitivity ; Precancerous Conditions - blood ; Precancerous Conditions - epidemiology ; Precancerous Conditions - pathology ; Precancerous Conditions - virology ; Serology ; Serum biomarkers ; Stomach Neoplasms - blood ; Stomach Neoplasms - epidemiology ; Stomach Neoplasms - pathology ; Stomach Neoplasms - virology ; Toxoplasmosis ; Trefoil factor ; Trefoil Factor-3 - blood</subject><ispartof>Cancer epidemiology, 2020-08, Vol.67, p.101726-101726, Article 101726</ispartof><rights>2020</rights><rights>Copyright © 2020. Published by Elsevier Ltd.</rights><rights>Copyright Elsevier Limited Aug 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c487t-60c29872f99c7970de4c8819b9b2f0eb6d43057cfd543980d99a6249f023f13b3</citedby><cites>FETCH-LOGICAL-c487t-60c29872f99c7970de4c8819b9b2f0eb6d43057cfd543980d99a6249f023f13b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2425586865?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32447242$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Whary, Mark T.</creatorcontrib><creatorcontrib>Avenia, Jose M. Restrepo</creatorcontrib><creatorcontrib>Bravo, Luis E.</creatorcontrib><creatorcontrib>Lofgren, Jennifer L.</creatorcontrib><creatorcontrib>Lertpiriyapong, Kvin</creatorcontrib><creatorcontrib>Mera-Giler, Robertino</creatorcontrib><creatorcontrib>Piazuelo, M. Blanca</creatorcontrib><creatorcontrib>Correa, Pelayo</creatorcontrib><creatorcontrib>Peek, Richard M.</creatorcontrib><creatorcontrib>Wilson, Keith T.</creatorcontrib><creatorcontrib>Fox, James G.</creatorcontrib><title>Contrasting serum biomarker profiles in two Colombian populations with different risks for progression of premalignant gastric lesions during chronic Helicobacter pylori infection</title><title>Cancer epidemiology</title><addtitle>Cancer Epidemiol</addtitle><description>•Coastal Colombians have lower Helicobacter pylori-associated gastric cancer compared to the Andes despite comparable infection and gastritis.•Lesion progression was associated with significant odds ratios for serum IL-5, trefoil factor 3 (TFF3), and low pepsinogen I/II ratio.•Low risk patients had elevated serum inflammatory biomarkers that reflect higher exposure to infectious diseases beyond H. pylori.•Data suggest IL-5, TFF3 and pepsinogen I/II ratios should be evaluated in combination to predict aggressive gastric histology.
Colombians in coastal Tumaco have a lower incidence of Helicobacter pylori-associated gastric cancer compared to individuals from Tuquerres in the high Andes. This is despite nearly universal prevalence of H. pylori infection and chronic gastritis.
H. pylori infection was confirmed by Steiner stain and serology using African and European-origin strains. Gastric histology and serum inflammatory biomarkers in dyspeptic Tumaco or Tuquerres patients were evaluated to predict progression of gastric lesions.
H. pylori infection was nearly universal by Steiner stain and serology. IgG response to European-origin H. pylori strains were greater than African-origin. High gastric cancer-risk Tuquerres patients, compared to low-risk Tumaco, had significant odds ratios for lesion progression associated with serum IL-5, trefoil factor 3 (TFF3), and low pepsinogen I/II ratio. Sensitivity and specificity for these parameters was 63.8% and 67.9%, respectively, with correctly classifying patients at 66.7%. Most odds ratios for 26 other biomarkers were significant for the town of residency, indicating an environmental impact on Tumaco patients associated with decreased lesion progression.
An IL-5 association with progression of gastric lesions is novel and could be evaluated in addition to TFF3 and pepsinogen I/II ratio as a non-invasive prognostic screen. Results suggest Tumaco patients were exposed to infectious diseases beyond H. pylori such as the documented high incidence of helminthiasis and toxoplasmosis.
Results support a prior recommendation to evaluate TFF3 and pepsinogen I/II together to predict aggressive gastric histology. Our data indicate IL-5 should be further evaluated as prognostic parameter.</description><subject>Adult</subject><subject>Biomarkers</subject><subject>Biomarkers - blood</subject><subject>Biopsy</subject><subject>Cancer</subject><subject>Case-Control Studies</subject><subject>Chemokines</subject><subject>Chronic infection</subject><subject>Colombia</subject><subject>Colombia - epidemiology</subject><subject>Cytokines</subject><subject>Environmental impact</subject><subject>Epidemiology</subject><subject>Evaluation</subject><subject>Female</subject><subject>Gastric cancer</subject><subject>Gastritis</subject><subject>Health risks</subject><subject>Helicobacter Infections - complications</subject><subject>Helicobacter Infections - virology</subject><subject>Helicobacter pylori</subject><subject>Helicobacter pylori - isolation & purification</subject><subject>Helminthiasis</subject><subject>Histology</subject><subject>Histopathology</subject><subject>Humans</subject><subject>Immunoglobulin G</subject><subject>Incidence</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Inflammation</subject><subject>Interleukin 5</subject><subject>Interleukin-5 - blood</subject><subject>Lesions</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Parameter sensitivity</subject><subject>Precancerous Conditions - blood</subject><subject>Precancerous Conditions - epidemiology</subject><subject>Precancerous Conditions - pathology</subject><subject>Precancerous Conditions - virology</subject><subject>Serology</subject><subject>Serum biomarkers</subject><subject>Stomach Neoplasms - blood</subject><subject>Stomach Neoplasms - epidemiology</subject><subject>Stomach Neoplasms - pathology</subject><subject>Stomach Neoplasms - virology</subject><subject>Toxoplasmosis</subject><subject>Trefoil factor</subject><subject>Trefoil Factor-3 - blood</subject><issn>1877-7821</issn><issn>1877-783X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9Uk1v1DAUjBCIlsIvQEKWuHDZxXE-HB9AqlZAkSpxAYmb5TjP2bd17GAnrfq7-IM42bICDpxsP8-bNx5Plr3M6Tanef32sNXKwbhllK0VzupH2XnecL7hTfH98WnP8rPsWYwHSus6z6un2VnBypKzkp1nP3feTUHFCV1PIoR5IC36QYUbCGQM3qCFSNCR6c6Tnbd-aFE5MvpxtmpC7yK5w2lPOjQGAriJBIw3kRi_tvcBYkwo4k06wqAs9k4lVJ9GBtQksa8k3RwWBXofvEvlK7Cofav0tMi4tz5gEmFALyOfZ0-MshFePKwX2bePH77urjbXXz593l1eb3TZ8GlTU81Ew5kRQnPBaQelbppctKJlhkJbd2VBK65NV5WFaGgnhKpZKQxlhcmLtrjI3h95x7kdoNOwOGXlGDD5cy-9Qvn3jcO97P2t5LyqqrpKBG8eCIL_MUOc5IBRg7Xp3_wcJStpXXFGqUjQ1_9AD34OLj0voVhVNXWzEhZHlA4-xgDmJCancgmFPMg1FHIJhTyGInW9-vMdp57fKUiAd0cAJDdvEYKMGsFp6DAky2Xn8b8DfgFt5c9s</recordid><startdate>20200801</startdate><enddate>20200801</enddate><creator>Whary, Mark T.</creator><creator>Avenia, Jose M. Restrepo</creator><creator>Bravo, Luis E.</creator><creator>Lofgren, Jennifer L.</creator><creator>Lertpiriyapong, Kvin</creator><creator>Mera-Giler, Robertino</creator><creator>Piazuelo, M. Blanca</creator><creator>Correa, Pelayo</creator><creator>Peek, Richard M.</creator><creator>Wilson, Keith T.</creator><creator>Fox, James G.</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200801</creationdate><title>Contrasting serum biomarker profiles in two Colombian populations with different risks for progression of premalignant gastric lesions during chronic Helicobacter pylori infection</title><author>Whary, Mark T. ; Avenia, Jose M. Restrepo ; Bravo, Luis E. ; Lofgren, Jennifer L. ; Lertpiriyapong, Kvin ; Mera-Giler, Robertino ; Piazuelo, M. Blanca ; Correa, Pelayo ; Peek, Richard M. ; Wilson, Keith T. ; Fox, James G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c487t-60c29872f99c7970de4c8819b9b2f0eb6d43057cfd543980d99a6249f023f13b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Biomarkers</topic><topic>Biomarkers - blood</topic><topic>Biopsy</topic><topic>Cancer</topic><topic>Case-Control Studies</topic><topic>Chemokines</topic><topic>Chronic infection</topic><topic>Colombia</topic><topic>Colombia - epidemiology</topic><topic>Cytokines</topic><topic>Environmental impact</topic><topic>Epidemiology</topic><topic>Evaluation</topic><topic>Female</topic><topic>Gastric cancer</topic><topic>Gastritis</topic><topic>Health risks</topic><topic>Helicobacter Infections - complications</topic><topic>Helicobacter Infections - virology</topic><topic>Helicobacter pylori</topic><topic>Helicobacter pylori - isolation & purification</topic><topic>Helminthiasis</topic><topic>Histology</topic><topic>Histopathology</topic><topic>Humans</topic><topic>Immunoglobulin G</topic><topic>Incidence</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Inflammation</topic><topic>Interleukin 5</topic><topic>Interleukin-5 - blood</topic><topic>Lesions</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Parameter sensitivity</topic><topic>Precancerous Conditions - blood</topic><topic>Precancerous Conditions - epidemiology</topic><topic>Precancerous Conditions - pathology</topic><topic>Precancerous Conditions - virology</topic><topic>Serology</topic><topic>Serum biomarkers</topic><topic>Stomach Neoplasms - blood</topic><topic>Stomach Neoplasms - epidemiology</topic><topic>Stomach Neoplasms - pathology</topic><topic>Stomach Neoplasms - virology</topic><topic>Toxoplasmosis</topic><topic>Trefoil factor</topic><topic>Trefoil Factor-3 - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Whary, Mark T.</creatorcontrib><creatorcontrib>Avenia, Jose M. Restrepo</creatorcontrib><creatorcontrib>Bravo, Luis E.</creatorcontrib><creatorcontrib>Lofgren, Jennifer L.</creatorcontrib><creatorcontrib>Lertpiriyapong, Kvin</creatorcontrib><creatorcontrib>Mera-Giler, Robertino</creatorcontrib><creatorcontrib>Piazuelo, M. Blanca</creatorcontrib><creatorcontrib>Correa, Pelayo</creatorcontrib><creatorcontrib>Peek, Richard M.</creatorcontrib><creatorcontrib>Wilson, Keith T.</creatorcontrib><creatorcontrib>Fox, James G.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer epidemiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Whary, Mark T.</au><au>Avenia, Jose M. Restrepo</au><au>Bravo, Luis E.</au><au>Lofgren, Jennifer L.</au><au>Lertpiriyapong, Kvin</au><au>Mera-Giler, Robertino</au><au>Piazuelo, M. Blanca</au><au>Correa, Pelayo</au><au>Peek, Richard M.</au><au>Wilson, Keith T.</au><au>Fox, James G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Contrasting serum biomarker profiles in two Colombian populations with different risks for progression of premalignant gastric lesions during chronic Helicobacter pylori infection</atitle><jtitle>Cancer epidemiology</jtitle><addtitle>Cancer Epidemiol</addtitle><date>2020-08-01</date><risdate>2020</risdate><volume>67</volume><spage>101726</spage><epage>101726</epage><pages>101726-101726</pages><artnum>101726</artnum><issn>1877-7821</issn><eissn>1877-783X</eissn><abstract>•Coastal Colombians have lower Helicobacter pylori-associated gastric cancer compared to the Andes despite comparable infection and gastritis.•Lesion progression was associated with significant odds ratios for serum IL-5, trefoil factor 3 (TFF3), and low pepsinogen I/II ratio.•Low risk patients had elevated serum inflammatory biomarkers that reflect higher exposure to infectious diseases beyond H. pylori.•Data suggest IL-5, TFF3 and pepsinogen I/II ratios should be evaluated in combination to predict aggressive gastric histology.
Colombians in coastal Tumaco have a lower incidence of Helicobacter pylori-associated gastric cancer compared to individuals from Tuquerres in the high Andes. This is despite nearly universal prevalence of H. pylori infection and chronic gastritis.
H. pylori infection was confirmed by Steiner stain and serology using African and European-origin strains. Gastric histology and serum inflammatory biomarkers in dyspeptic Tumaco or Tuquerres patients were evaluated to predict progression of gastric lesions.
H. pylori infection was nearly universal by Steiner stain and serology. IgG response to European-origin H. pylori strains were greater than African-origin. High gastric cancer-risk Tuquerres patients, compared to low-risk Tumaco, had significant odds ratios for lesion progression associated with serum IL-5, trefoil factor 3 (TFF3), and low pepsinogen I/II ratio. Sensitivity and specificity for these parameters was 63.8% and 67.9%, respectively, with correctly classifying patients at 66.7%. Most odds ratios for 26 other biomarkers were significant for the town of residency, indicating an environmental impact on Tumaco patients associated with decreased lesion progression.
An IL-5 association with progression of gastric lesions is novel and could be evaluated in addition to TFF3 and pepsinogen I/II ratio as a non-invasive prognostic screen. Results suggest Tumaco patients were exposed to infectious diseases beyond H. pylori such as the documented high incidence of helminthiasis and toxoplasmosis.
Results support a prior recommendation to evaluate TFF3 and pepsinogen I/II together to predict aggressive gastric histology. Our data indicate IL-5 should be further evaluated as prognostic parameter.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>32447242</pmid><doi>10.1016/j.canep.2020.101726</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1877-7821 |
ispartof | Cancer epidemiology, 2020-08, Vol.67, p.101726-101726, Article 101726 |
issn | 1877-7821 1877-783X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7755565 |
source | MEDLINE; Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland |
subjects | Adult Biomarkers Biomarkers - blood Biopsy Cancer Case-Control Studies Chemokines Chronic infection Colombia Colombia - epidemiology Cytokines Environmental impact Epidemiology Evaluation Female Gastric cancer Gastritis Health risks Helicobacter Infections - complications Helicobacter Infections - virology Helicobacter pylori Helicobacter pylori - isolation & purification Helminthiasis Histology Histopathology Humans Immunoglobulin G Incidence Infections Infectious diseases Inflammation Interleukin 5 Interleukin-5 - blood Lesions Male Middle Aged Parameter sensitivity Precancerous Conditions - blood Precancerous Conditions - epidemiology Precancerous Conditions - pathology Precancerous Conditions - virology Serology Serum biomarkers Stomach Neoplasms - blood Stomach Neoplasms - epidemiology Stomach Neoplasms - pathology Stomach Neoplasms - virology Toxoplasmosis Trefoil factor Trefoil Factor-3 - blood |
title | Contrasting serum biomarker profiles in two Colombian populations with different risks for progression of premalignant gastric lesions during chronic Helicobacter pylori infection |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T15%3A32%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Contrasting%20serum%20biomarker%20profiles%20in%20two%20Colombian%20populations%20with%20different%20risks%20for%20progression%20of%20premalignant%20gastric%20lesions%20during%20chronic%20Helicobacter%20pylori%20infection&rft.jtitle=Cancer%20epidemiology&rft.au=Whary,%20Mark%20T.&rft.date=2020-08-01&rft.volume=67&rft.spage=101726&rft.epage=101726&rft.pages=101726-101726&rft.artnum=101726&rft.issn=1877-7821&rft.eissn=1877-783X&rft_id=info:doi/10.1016/j.canep.2020.101726&rft_dat=%3Cproquest_pubme%3E2425586865%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2425586865&rft_id=info:pmid/32447242&rft_els_id=S1877782120300606&rfr_iscdi=true |